Live Breaking News & Updates on பளபளப்பு ஆயுட்காலம் லிமிடெட்

Stay updated with breaking news from பளபளப்பு ஆயுட்காலம் லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Glow LifeTech Reports on Additional Research Results on ArtemiC and


Article content
The results, announced on May 7, 2021, demonstrate the mechanism of action of ArtemiC™ is to reduce inflammation and suppress the cytokine storm
2 – believed to be the one of the leading causes of mortality in COVID-19 patients
3. The results show that ArtemiC™ decreases the markers of inflammation (IFN-g, IL-1a and TNF-a), in the bronchoalveolar lavage fluid (BALF) of mice in the animal model of cytokine storm related to COVID-19. The clinical and preclinical results to date support ArtemiC™ being effective for addressing cytokine overproduction which is found in different variants and mutations of COVID-19.
“ArtemiC™ focuses on preventing and reducing the severity of the cytokine storm and hyper-inflammation induced by respiratory viruses, and since all current COVID-19 variants of concern may lead to a cytokine storm, the preclinical and clinical results support that ArtemiC™ should be effective on COVID-19 variants,” said Tom Gl ....

Rob Carducci , Tom Glawdel , Glow Lifetech Ltd , Glow Lifetech Corp , Pharmaceuticals Ltd , Newsfile Corp , Health Canada Natural , Mycell Technology , Micelle Technology , Swiss Pharmacan Ag Micelle Technology , Placebo Group , Health Canada , Health Products Directorate , Glow Lifetech Reports , Additional Research Results , Positive Implications , Glow Lifetech , Chief Operating Officer , Chief Commercial Officer , Non Prescription Health Products Directorate , Swiss Pharmacan , கொள்ளை கார்டுக்ஸி , பளபளப்பு ஆயுட்காலம் லிமிடெட் , பளபளப்பு ஆயுட்காலம் கார்ப் , மருந்துகள் லிமிடெட் , ஆரோக்கியம் கனடா இயற்கை ,

Glow LifeTech Corp.: Glow LifeTech Announces Successful First Commercial Production of ArtemiC for Global Distributor and a Second Production Scaled to Meet Growing Global Demand


Glow LifeTech Corp.: Glow LifeTech Announces Successful First Commercial Production of ArtemiC for Global Distributor and a Second Production Scaled to Meet Growing Global Demand
Glow or the
Company ), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce the successful delivery of the first commercial production run of ArtemiC at its supply partner, Swiss PharmaCan AG ( SPC ) in April 2021
1, and a second production run worth nearly $1 million
2 CAD that is scaled to service the growing demand around the world.
Glow ArtemiC
https://orders.newsfilecorp.com/files/3920/82873 9c83b087946a5903 001full.jpg
Building on the Company s recent application to Health Canada for its natural oral spray, ArtemiC, following its successful COVID-19 Phase II clinical trial (see Glow s release dated April 27, 2021), the Company s strategic focus is on expediting the launch of ArtemiC in Canada and beyond as ....

United States , W Clark Kent , Rob Carducci , Tom Glawdel , Bernhard Langer , Glow Lifetech Ltd , Glow Lifetech Corp , Pharmaceuticals Ltd , Health Canada Natural , Newsfile Corp , Mycell Technology , Micelle Technology , Swiss Pharmacan Ag Micelle Technology , Health Canada , Health Products Directorate , Swiss Pharmacan , Chief Commercial Officer , Chief Operating Officer , Non Prescription Health Products Directorate , Once Health Canada , Natural Product Number , Relay Medical , ஒன்றுபட்டது மாநிலங்களில் , டப்ல்யூ கிளார்க் கேண்ட் , கொள்ளை கார்டுக்ஸி , பெர்ன்ஹார்ட் லாங்கர் ,